Efficacy and safety of canagliflozin in subjects with type 2 diabetes and chronic kidney disease

Por Yale, J-F, Bakris, G, Cariou, B, Yue, D, David-Neto, E, Xi, L, Figueroa, K, Wajs, E, Usiskin, K, Meininger, G
Publicado em 2013